Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04417088 |
Recruitment Status :
Active, not recruiting
First Posted : June 4, 2020
Last Update Posted : March 5, 2024
|
Sponsor:
InSightec
Information provided by (Responsible Party):
InSightec
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | December 31, 2023 |
Estimated Study Completion Date : | July 2024 |